z-logo
open-access-imgOpen Access
Role of diffusion-weighted MR imaging in discrimination between the intracranial cystic masses
Author(s) -
Ahmed Yousef,
Amany Elkharbotly,
Magdy Settin,
Yasser Mousa
Publication year - 2014
Publication title -
the egyptian journal of radiology and nuclear medicine /the egyptian journal of radiology and nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 13
eISSN - 2090-4762
pISSN - 0378-603X
DOI - 10.1016/j.ejrnm.2014.04.011
Subject(s) - medicine , effective diffusion coefficient , echo planar imaging , magnetic resonance imaging , radiology , diffusion mri , nuclear medicine , diffusion imaging
Objective: Discriminating pyogenic brain abscesses from cystic or necrotic tumors is sometimes difficult with CT or conventional MR imaging. Diffusion MR imaging is a valuable diagnostic test in cases of intracranial cystic masses.Methods: This work was conducted from July 2008 to June 2013 on 90 patients; 43 males and 47 females. Their ages range from 5 to 70 years. All patients were subjected to routine MRI examination and diffusion weighted imaging using 1.5 T MRI scanner. Gadolinium was given to some cases on routine MRI. Diffusion weighted imaging was performed with a single-shot spin-echo echo-planar pulse sequence (b = 0–1000 s/mm2). The apparent diffusion coefficient values and ratio were measured.Results and conclusions: Patients in this study were categorized into three main groups; first group is brain abscesses (36 cases), 91.6% of them showed restricted diffusion, second group is malignant cystic or necrotic brain tumors, 28 cases of high grade necrotic glioma, 60.7% of them are free diffusion, and third group is benign cystic masses, arachnoid and epidermiod cysts (11 cases); all arachnoid cysts are free diffusion. From these results diffusion-weighted imaging is playing an important role in discrimination of cystic intracranial masses

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here